PSY101 - LONG-TERM COST-EFFECTIVENESS OF EUROFIT VERSUS WAITING LIST
نویسندگان
چکیده
منابع مشابه
Long Term Cost Effective Preventive Maintenance Scheduling
Preventive maintenance scheduling of generating units is addressed as a long-term scheduling in power system studies aiming to increase the reliability incorporating cost reduction. It consists of knowing which generating units should be shut down for regular safety inspection. In this paper, a new formulation of preventive maintenance scheduling associated with cost reduction index (CRI) is pr...
متن کاملCost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
BACKGROUND Survival after liver transplantation for early hepatocellular carcinoma (HCC) is worsened by the increasing dropout rate while waiting for a donor. AIMS To assess the cost effectiveness of adjuvant therapy while waiting for liver transplantation in HCC patients. METHOD Using a Markov model, a hypothetical cohort of cirrhotic patients with early HCC was considered for: (1) adjuvan...
متن کاملLong term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction.
OBJECTIVE To investigate the long term clinical outcome and cost-effectiveness of stenting compared with balloon angioplasty in patients with acute myocardial infarction. METHODS Patients with acute myocardial infarction were randomly allocated to primary stenting (112) or balloon angioplasty (115). The primary end point was the cumulative first event rate of death, non-fatal reinfarction, or...
متن کاملIDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting
INTRODUCTION Treatment with IDegLira has the potential to improve glycemic control in patients with type 2 diabetes mellitus (T2DM) without the weight gain and with a lower risk of hypoglycemia than with other therapies. The aim of the present analysis was to evaluate the long-term cost-effectiveness of IDegLira versus insulin glargine U100 with re-education and up-titration of the dose for tre...
متن کاملLong-term cost-effectiveness of clopidogrel in STEMI patients.
BACKGROUND The COMMIT trial demonstrated that clopidogrel produced a 9% relative reduction in death, reinfarction or stroke (9.2% vs. 10.1%, 95% CI: 0.86-0.97) in ST-elevated myocardial infarction (STEMI) patients. METHODS Between 08/1999 and 05/2005, 45,852 STEMI patients were randomized to clopidogrel (n=22,961) or matching placebo (n=22,891) in addition to aspirin. The rate of initial hosp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2018
ISSN: 1098-3015
DOI: 10.1016/j.jval.2018.09.2676